PV
Pierre Vandepapelière
Chief Executive Officer, Chief Medical Officer and Founder at Amyl Therapeutics
Belgium, Belgium
About
Pierre Vandepapelière is a Chief Executive Officer, Chief Medical Officer and Founder at Amyl Therapeutics. Pierre Vandepapelière attended Université catholique de Louvain.
Position in the VCSift Database
- • 2 investors at Amyl Therapeutics are tracked.
- • 1 investors hold the Chief Executive Officer, Chief Medical Officer and Founder role in VCSift. Pierre Vandepapelière is one of them.
- • 48 investors are based in Belgium.
Data sourced from 410,343 investor profiles. Updated October 2026.
Investment Focus
- Location
- Belgium
Contact Information
linkedin.com/in/••••••••
Find more investors like Pierre
Search Investors